دانلود مقاله ISI انگلیسی شماره 72471
عنوان فارسی مقاله

مصرف مواد و پاسخ به درمان روانپزشکی در بیماران تحت درمان متادون با ابتلای همزمان به اختلال روانی

کد مقاله سال انتشار مقاله انگلیسی ترجمه فارسی تعداد کلمات
72471 2015 6 صفحه PDF سفارش دهید محاسبه نشده
خرید مقاله
پس از پرداخت، فوراً می توانید مقاله را دانلود فرمایید.
عنوان انگلیسی
Substance Use and Response to Psychiatric Treatment in Methadone-Treated Outpatients with Comorbid Psychiatric Disorder
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Journal of Substance Abuse Treatment, Volume 51, April 2015, Pages 64–69

کلمات کلیدی
وابستگی به مواد افیونی؛ نگهدارنده با متادون؛ درمان های روانی؛
پیش نمایش مقاله
پیش نمایش مقاله مصرف مواد و پاسخ به درمان روانپزشکی در بیماران تحت درمان متادون با ابتلای همزمان به اختلال روانی

چکیده انگلیسی

The psychiatric care of opioid users receiving agonist therapies is often complicated by high rates of illicit drug use (Brooner et al., 2013). The present study evaluates if illicit drug use (i.e., opioids, cocaine, sedatives) detected at the start of psychiatric care affects treatment response. Methadone maintenance patients (n = 125) with at least one current psychiatric disorder completed a 3-month randomized clinical trial evaluating the efficacy of financial incentives on attendance to on-site integrated substance abuse and psychiatric services (Kidorf et al., 2013). The present study re-analyzes the data set by grouping participants into one of two conditions based on the 4-week baseline observation: (1) no illicit drug use (baseline negative; n = 50), or (2) any illicit drug use (baseline positive; n = 75). All participants received a similar schedule of psychiatric services, and had good access to prescribed psychiatric medications. The Global Severity Index (GSI) of the Hopkins Symptom Checklist-Revised was administered monthly to evaluate changes in psychiatric distress. Results showed that while both conditions evidenced similar utilization of on-site psychiatric services, baseline negative participants remained in treatment somewhat longer (80.7 vs. 74.8 days, p = .04) and demonstrated greater reductions in GSI scores than baseline positive participants at month 3 (p = .004). These results have implications for interpreting previous studies that have shown inconsistent efficacy of pharmacotherapy and other psychiatric treatments, and for providing clinical care for patients with co-occurring substance use and psychiatric disorders.

خرید مقاله
پس از پرداخت، فوراً می توانید مقاله را دانلود فرمایید.